Enhanced therapeutic potential of AEBP1 silencing via engineered apoptotic mesenchymal stem cell-derived nanovesicles in atrial fibrillation

30 August 2025 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Mechanisms, biomarkers, and therapeutic targets in atrial fibrillation Gene Therapy, Cell Therapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology